Update in Lung Cancer Molecular Pathology: Technological Advances and Clinical Practice-Reference-Cited by-同舟云学术

Update in Lung Cancer Molecular Pathology: Technological Advances and Clinical Practice

Published:2023-07-27 Issue:15 Volume:15 Page:3812
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Graziano Paolo¹^ORCID,Rossi Giulio²^ORCID

Affiliation:

1. Services Department, Pathology Unit, Scientific Institute for Research and Health Care (IRCCS) “Casa Sollievo della Sofferenza”, Viale Cappuccini 1, 71013 San Giovanni Rotondo, Italy

2. Services Department, Pathology Unit, Fondazione Poliambulanza Hospital Institute, Via Bissolati 57, 25124 Brescia, Italy

Abstract

This Special Issue of eleven articles, including six original works and five reviews, demonstrates the modern heterogenous approach to lung cancer by means of various methodologies from international experts from various countries [...]

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

https://www.mdpi.com/2072-6694/15/15/3812/pdf

Reference12 articles.

1. NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023;Ettinger;J. Natl. Compr. Cancer Netw.,2023

2. An, H.J., An, E., Rabizadeh, S., Liao, W.-L., Burrows, J., Hembrough, T., Kang, J.H., Park, C.K., and Kim, T.-J. (2021). Quantitative Multiplexed Proteomics Could Assist Therapeutic Decision Making in Non-Small Cell Lung Cancer Patients with Ambiguous ALK Test Results. Cancers, 13.

3. Leone, A., Muscarella, L.A., Graziano, P., Tornese, A., Grillo, L.R., Di Lorenzo, A., Bronzini, M., Scarpino, S., Sparaneo, A., and Rossi, G. (2023). Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation. Cancers, 15.

4. Bironzo, P., Reale, M.L., Sperone, T., Tabbò, F., Caglio, A., Listì, A., Passiglia, F., Di Maio, M., Righi, L., and Bussolino, F. (2021). Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations. Cancers, 13.

5. Verzè, M., Minari, R., Gnetti, L., Bordi, P., Leonetti, A., Cosenza, A., Ferri, L., Majori, M., De Filippo, M., and Buti, S. (2021). Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature. Cancers, 13.